Related Experiment Videos
[Neuroprotection with carotenoids in glaucoma]
Oftalmologia (Bucharest, Romania : 1990)
|April 16, 2004
Summary
Natural carotenoids, lutein and zeaxanthin, show promise in mitigating glaucoma optic neuropathy by reducing retinal ganglion cell loss. Supplementation in guinea pigs demonstrated significant antioxidative effects, suggesting a potential role in glaucoma treatment.
Area of Science:
- Ophthalmology
- Nutritional Science
- Neuroscience
Context:
- Glaucoma optic neuropathy is a leading cause of irreversible blindness.
- Oxidative stress is implicated as a key factor in the pathogenesis of glaucoma.
- Natural carotenoids like lutein and zeaxanthin possess potent antioxidant properties.
Purpose:
- To evaluate the efficacy of natural carotenoids (lutein and zeaxanthin) in managing glaucoma optic neuropathy.
- To assess the impact of lutein and zeaxanthin supplementation on intraocular pressure (IOP) and retinal ganglion cell loss in a preclinical model.
Summary:
- An experimental study on guinea pigs with induced ocular hypertension demonstrated that dietary supplementation with lutein and zeaxanthin (IcapsL) led to higher serum carotenoid levels.
- Animals receiving lutein and zeaxanthin exhibited reduced loss of retinal ganglion cells (18.9%) compared to the control group (29.7%).
- Supplementation correlated with a lower cup-to-disc ratio and reduced axonal degeneration in the optic nerve head, suggesting a protective effect against glaucoma-induced damage.
Impact:
- Lutein and zeaxanthin may serve as a viable therapeutic strategy in the comprehensive management of glaucoma.
- This research highlights the potential of nutritional interventions in neuroprotective strategies for ocular diseases.
- Further clinical studies are warranted to confirm the therapeutic benefits of lutein and zeaxanthin in glaucoma patients.